Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 1,269,876,000
  • Shares Outstanding, K 42,800
  • 60-Month Beta 1.70
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.382 on 12/29/21
  • Management Fee 0.75%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 47.89% (+4.17%)
  • Historical Volatility 39.03%
  • IV Percentile 56%
  • IV Rank 35.88%
  • IV High 86.12% on 04/08/25
  • IV Low 26.49% on 07/22/25
  • Expected Move (DTE 4) 1.06 (3.58%)
  • Put/Call Vol Ratio 0.77
  • Today's Volume 1,729
  • Volume Avg (30-Day) 5,349
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 373,122
  • Open Int (30-Day) 410,434
  • Expected Range 28.61 to 30.73

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.89 +2.70%
on 12/18/25
31.97 -7.19%
on 12/04/25
-1.19 (-3.86%)
since 11/26/25
3-Month
26.04 +13.94%
on 11/14/25
34.06 -12.90%
on 10/20/25
+2.76 (+10.26%)
since 09/26/25
52-Week
17.50 +69.49%
on 04/07/25
34.06 -12.90%
on 10/20/25
+5.01 (+20.32%)
since 12/26/24

Most Recent Stories

More News
Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?

Cathie Wood is resolute on RXRX despite its slump. Should investors follow her lead into this AI-driven biotech bet now?

ARKG : 29.67 (-1.69%)
RXRX : 4.25 (-3.41%)
ARKK : 79.70 (-1.18%)
Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?)

These two companies fit the type of transformative growth story Cathie Wood seeks out.

ARKW : 151.70 (-1.80%)
ARKG : 29.67 (-1.69%)
RBRK : 78.66 (-0.18%)
PRME : 3.50 (-1.96%)
Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)

This dip in Illumina’s stock could be an attractive opportunity for long-term growth investors.

ARKG : 29.67 (-1.69%)
ILMN : 134.95 (-0.27%)
BMO Announces Final Valuations and Declares Final Distributions on Units of ETF Series of Terminated BMO Mutual Funds

/CNW/ - BMO Investments Inc. ("BMOII") today announced the final net asset values for the ETF Series of each of BMO ARK Genomic Revolution Fund (Cboe Canada:...

ARKG : 29.67 (-1.69%)
ARKW : 151.70 (-1.80%)
BMO : 130.94 (+0.34%)
ARKK : 79.70 (-1.18%)
Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.

ARKG : 29.67 (-1.69%)
SFTBY : 56.7600 (+1.61%)
TEM : 62.70 (-2.43%)
ARKK : 79.70 (-1.18%)
Best-Performing ETFs of Last Week

Wall Street was upbeat last week, with the S&P 500 adding 1.5%, the Dow Jones gaining about 0.6% and the Nasdaq surging 2.6%. Last week witnessed the release of hot January inflation data. The Consumer...

ODDS : 29.48 (+0.89%)
ABNY : 47.58 (-0.97%)
ARKG : 29.67 (-1.69%)
MS : 181.87 (+0.12%)
KWEB : 34.83 (+0.93%)
UNG : 12.81 (+3.39%)
Tempus AI Stock Swings Wildly As Earnings Near, Retail’s Cautiously Optimistic After Insider Sales

The company has gained a lot of attention since launching an AI-enabled personal health app last month.

ARKG : 29.67 (-1.69%)
IBB : 172.03 (-0.70%)
VTI : 339.67 (-0.06%)
TEM : 62.70 (-2.43%)
Cathie Wood Just Doubled Down on This AI Stock. Should You?

The stock is one of the renowned investor’s top holdings.

ARKG : 29.67 (-1.69%)
MRK : 106.78 (+0.31%)
TEM : 62.70 (-2.43%)
ARKK : 79.70 (-1.18%)
TAK : 15.65 (+0.45%)
BNTX : 94.52 (-0.54%)
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens

The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects.

ARKG : 29.67 (-1.69%)
IBB : 172.03 (-0.70%)
XBI : 124.98 (-1.05%)
NTLA : 9.44 (-1.56%)
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now

A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17.

ARKG : 29.67 (-1.69%)
IBBQ : 28.91 (-0.64%)
TEM : 62.70 (-2.43%)
ARKK : 79.70 (-1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Key Turning Points

3rd Resistance Point 30.67
2nd Resistance Point 30.38
1st Resistance Point 30.02
Last Price 29.67
1st Support Level 29.38
2nd Support Level 29.09
3rd Support Level 28.73

See More

52-Week High 34.06
Last Price 29.67
Fibonacci 61.8% 27.74
Fibonacci 50% 25.78
Fibonacci 38.2% 23.83
52-Week Low 17.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar